Bioactivity:

Repaglinide is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury.

CAS nr:

135062-02-1

Purity:

98%

Molecular Weight:

452,59

SMILES:

c1ccc(c(c1)[C@@H](NC(=O)Cc1cc(c(cc1)C(=O)O)OCC)CC(C)C)N1CCCCC1

Formula:

C27H36N2O4

Pathway:

DNA Damage/DNA Repair,Metabolism,Membrane transporter/Ion channel

Target:

PPAR,PPAR,Potassium Channel